The largest database of trusted experimental protocols

7 protocols using dithiothreitol dtt

1

Protein Immunoassay Protocol for GAD65, IA-2, and Insulin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full length GAD65 from RSR (#rGAD/FR/1) and insulin from Sigma Aldrich (#91077) were full-length recombinant proteins produced in yeast. The IA-2 antigen from RSR (#rIA2/FR/1) was a recombinant protein fragment from amino acid 604–979 produced in E. Coli. Polyclonal GAD antibodies were purchased from R&D systems (#AF2247). IA-2 antibodies were from Proteintech (#10584-1AP). insulin antibodies were from Abcam (#14042). Platinum Taq polymerase (#10966026) and SYBR qPCR 2X master mix (#4385610) was purchased from Thermo Fisher. Hemoglobin (#H7379), bilirubin (#B4126) and intralipid (#I141) were purchased from Sigma Aldrich. Dithiothreitol (DTT #202090) and sulfo-SMCC (#22122) were purchased from Life Technologies. DNA ligase (#A8101) was purchased from Lucigen. Other reagents are detailed in the method sections as appropriate.
+ Open protocol
+ Expand
2

Cell-Free Protein Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein synthesis was conducted in coupled transcription/translation reactions in a final volume of 25–80 μl. Cell-free synthesis reactions were composed of 40% (v/v) translationally active CHO lysate supplemented with HEPES-KOH (pH 7.6, f.c. 30 mM, Carl Roth GmbH), sodium acetate (f.c. 100 mM, Merck), Mg(OAc)2 (f.c. 3.9 mM, Merck), KOAc (f.c. 150 mM, Merck), amino acids (complete 100 μM, Merck), spermidin (f.c. 0.25 mM; Roche), Dithiothreitol (DTT, 2.5 mM, Life technologies GmbH) and energy regenerating components including creatine phosphokinase (f.c. 0.1 mg/ml, Roche), creatine phosphate (20 mM, Roche), ATP (1.75 mM, Roche) and GTP (0.3 mM, Roche). To allow for DNA transcription during cell-free protein synthesis, 1 U/μl T7 RNA polymerase, 0.3 mM of UTP (Roche) and CTP (Roche) and 0.1 mM of the cap analogue m7G(ppp)G (Prof. Edward Darzynkiewicz, Warsaw University, Poland) were added to the reaction. Additionally, PolyG primer (f.c. 12 µM, IBA) was supplemented. To monitor the protein quantity and quality, cell-free protein synthesis reactions were supplemented with radioactive 14C-leucine (f.c. 50 μM, specific radioactivity 66.67 dpm/pmol, Perkin Elmer). Batch synthesis reactions were incubated at 30°C for 3 h at 500 rpm (Thermomixer comfort, Eppendorf).
+ Open protocol
+ Expand
3

Chikungunya Virus Serum Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study included 63 human samples from two independent outbreaks in Malaysia. The Asian serum panel comprised 40 samples collected from patients 11–14 months after an Asian CHIKV outbreak in Bagan Panchor in 2006 [7 (link)]. The ECSA serum panel consisted of 23 samples from patients infected by ECSA strains in 2008–2010, collected 1–6 months after onset of symptoms, who were seen at the University Malaya Medical Centre in Kuala Lumpur [9 (link)]. Healthy controls (n = 15) with no past infection of CHIKV served as negative controls. Serum neutralization assay was performed on all the sera. To determine the neutralizing activity due to IgG, heat-inactivated sera were treated for 1 hour with dithiothreitol (DTT) (Life Technologies) at a final concentration of 5mM at 37°C.
+ Open protocol
+ Expand
4

RNA Extraction and cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells or tissues were homogenized in RNA Stat60® and total RNA extracted using standard phenol-chloroform protocols followed by DNase treatment of the extracted RNA using RNA-II purification kit (Nachery-Nagel). A total of 100 ng of RNA per sample was converted into cDNA using Superscript II (Life Technologies) at 42 °C for 50 min, 70 °C 15 min, in the presence of 5 uM oligo (dT)16–18, 5 mM Dithiothreitol (DTT), 0.5 mM dNTPs (all Life Technologies), 8 U RNAsin (Promega), 50 mM Tris-HCl pH 8.3, 75 mM KCl and 3 mM MgCl2. The cDNA was treated with 2.5 U RNase H (Affymetrix) at 37 °C for 20 min to remove any remaining RNA residues.
+ Open protocol
+ Expand
5

RNA Extraction and cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells or tissue were homogenized in RNA Stat60® and total RNA extracted using standard phenol-chloroform protocols followed by DNase treatment of RNA extracted using RNA-II purification kit (Nachery-Nagel). A total of 100ng of RNA per sample was converted into cDNA using Superscript II (Life Technologies) at 42°C for 50min, 70°C 15min, in the presence of 5uM oligo (dT)16–18, 5mM Dithiothreitol (DTT), 0.5mM dNTPs (all Life Technologies), 8U RNAsin (Promega), 50mM Tris-HCl pH8.3, 75mM KCl and 3mM MgCl2. The cDNA was treated with 2.5U RNAse H (Affymetrix) at 37°C for 20min to remove any remaining RNA residues.
+ Open protocol
+ Expand
6

Enterocyte Isolation from Rat Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents were purchased from Sigma-Aldrich (UK) or Life Technologies (UK) unless otherwise stated. Aliquots of Dithiothreitol (DTT) (Life Technologies) were pre-prepared in distilled H2O and stored at −20°C. The wash solution (mucolytic solution) used in the initial steps of enterocyte isolation contained 1% penicillin/streptomycin and an aliquot of DTT dissolved in Hanks Buffered Saline Solution (HBSS) with MgCl2 and CaCl2 which gave a final concentration of 1 mM. Fresh wash solutions were made for each isolation due to DTT's reduced activity at room temperature as previously observed by Goodyear et al. (2014) (link). Solution formulations can vary between manufacturers and significantly impact the type and success of primary cultures of RT tissue as previously observed by Ganassin and Bols (1996) (link) in cultures of RT spleen. As such, trypsin (25050014), versene (15040033) and trypsin/EDTA (25300054) were purchased from Life Technologies. The enzyme digestion solution contained 0.1% collagenase D (COLLD-RO, Roche) and dispase II (D4694, Sigma-Aldrich) (equivalent to 1 mg/ml) with DNase (0.1 mg/ml) and 1% FBS/BSA. This solution is pre-warmed to 37°C prior to enterocyte isolation as is routine in many primary culture protocols.
+ Open protocol
+ Expand
7

RhAT N-glycan Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RhAT was produced at Kyowa Kirin (Tokyo, Japan), phAT was purchased from Japan Blood Products Organization (Tokyo, Japan), N-glycosidase F (PNGase F) was purchased from New England Biolabs (NEB) (Ipswich, MA), 2-aminobenzamide (2-AB) and tris(hydroxymethyl)aminomethane (Tris) were purchased from Nacalai Tesque (Tokyo, Japan), NaBH3CN, dimethylsulfoxide (DMSO) and iodoacetoamide (IAM) were purchased from Sigma-Aldrich (St. Louis, MO), acetic acid, acetonitrile, sodium acetate, sodium hydroxide, sodium dodecyl sulfate (SDS), disodium hydrogenphosphate, citric acid, and sodium bicarbonate were purchased from Wako Pure Chemical Industries (Tokyo, Japan), guanidine HCl was purchased from MP Biomedicals (Santa Ana, CA), 2,5-dihydroxybenzoic acid (DHB) was purchased from Waters (Milford, MA), peptidyl-Asp metalloendopeptidase (Asp-N) was purchased from Promega (Fitchburg, WI), neuraminidase was purchased from Roche Diagnostics (Risch-Rotkreuz, Switzerland), β-galactosidase was purchased from Calbiochem (Hayward, CA), SDS gel buffer, bare fused-silica capillary and 5-carboxytetramethylrhodamine succinimidyl ester (5-TAMRA SE) were purchased from Beckman Coulter, Inc. (Fullerton, CA), NAP-5 columns was purchased from GE Healthcare Life Sciences (Piscataway, NJ), dithiothreitol (DTT) was purchased from Life technologies (Carlsbad, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!